Badri Dasu's Insider Trades & SAST Disclosures
Badri Dasu's most recent trade in Talphera Inc. was a trade of 80,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 2, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Badri Dasu.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Talphera Inc. | Badri Dasu | Chief Engineering Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2025 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Talphera Inc. | Badri Dasu | Chief Engineering Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2025 | 15,000 | 42,011 (0%) | 0% | 0 | Common Stock | |
| Talphera Inc. | Badri Dasu | Chief Engineering Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. | 14 Feb 2025 | 2,644 | 27,011 (0%) | 0% | 0.7 | 1,771 | Common Stock |
| Talphera Inc. | Badri Dasu | Chief Engineering Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 10 Feb 2025 | 880 | 29,655 (0%) | 0% | 0.6 | 546 | Common stock |
| Talphera Inc. | Badri Dasu | Chief Engineering Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.63 per share. | 10 Feb 2025 | 879 | 30,535 (0%) | 0% | 0.6 | 554 | Common Stock |
| Talphera Inc. | Badri Dasu | Chief Engineering Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.30 per share. | 03 Mar 2024 | 406 | 31,414 (0%) | 0% | 1.3 | 528 | Common Stock |
| Talphera Inc. | Badri Dasu | Chief Engineering Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 88,000 | 88,000 | - | - | Stock Option (Right to Buy) | |
| Talphera Inc. | Badri Dasu | Chief Engineering Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 14,667 | 31,820 (0%) | 0% | 0 | Common Stock | |
| Talphera Inc. | Badri Dasu | Chief Engineering Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.10 per share. | 10 Feb 2024 | 809 | 17,153 (0%) | 0% | 1.1 | 890 | Common Stock |
| Talphera Inc. | Badri Dasu | Chief Engineering Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.10 per share. | 10 Feb 2024 | 809 | 17,962 (0%) | 0% | 1.1 | 890 | Common Stock |
| Acelrx Pharmaceuticals Inc | Badri Dasu | Chief Engineering Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.31 per share. | 03 Mar 2023 | 398 | 18,771 (0%) | 0% | 1.3 | 521 | Common Stock |
| Acelrx Pharmaceuticals Inc | Badri Dasu | Chief Engineering Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 29,250 | 29,250 | - | - | Stock Option (Right to Buy) | |
| Acelrx Pharmaceuticals Inc | Badri Dasu | Chief Engineering Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 4,875 | 19,945 (0%) | 0% | 0 | Common Stock | |
| Acelrx Pharmaceuticals Inc | Badri Dasu | Chief Engineering Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.68 per share. | 10 Feb 2023 | 776 | 19,169 (0%) | 0% | 1.7 | 1,304 | Common Stock |
| Acelrx Pharmaceuticals Inc | Badri Dasu | Chief Engineering Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.02 per share. | 06 Feb 2023 | 458 | 15,070 (0%) | 0% | 2.0 | 925 | Common Stock |
| Acelrx Pharmaceuticals Inc | Badri Dasu | Chief Engineering Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.41 per share. | 03 Mar 2022 | 5,612 | 300,595 (0%) | 0% | 0.4 | 2,283 | Common Stock |
| Acelrx Pharmaceuticals Inc | Badri Dasu | Chief Engineering Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 195,000 | 195,000 | - | - | Stock Option (Right to Buy) | |
| Acelrx Pharmaceuticals Inc | Badri Dasu | Chief Engineering Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 97,500 | 301,822 (0%) | 0% | 0 | Common Stock | |
| Acelrx Pharmaceuticals Inc | Badri Dasu | Chief Engineering Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.40 per share. | 11 Feb 2022 | 5,615 | 296,207 (0%) | 0% | 0.4 | 2,254 | Common Stock |
| Acelrx Pharmaceuticals Inc | Badri Dasu | Chief Engineering Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.43 per share. | 06 Feb 2022 | 6,830 | 204,322 (0%) | 0% | 0.4 | 2,945 | Common Stock |
| Acelrx Pharmaceuticals Inc | Badri Dasu | Chief Engineering Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Acelrx Pharmaceuticals Inc | Badri Dasu | Chief Engineering Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 50,000 | 204,757 (0%) | 0% | 0 | Common Stock | |
| Acelrx Pharmaceuticals Inc | Badri Dasu | Chief Engineering Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Acelrx Pharmaceuticals Inc | Badri Dasu | Chief Engineering Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.63 per share. | 11 Feb 2021 | 6,775 | 144,757 (0%) | 0% | 2.6 | 17,818 | Common Stock |
| Acelrx Pharmaceuticals Inc | Badri Dasu | Chief Engineering Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.59 per share. | 06 Feb 2021 | 6,846 | 151,532 (0%) | 0% | 2.6 | 17,731 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges